Corcept names Roberto Vieira as President, Oncology in initial beneficial ownership filing

Reuters2026/09/04 00:40

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Corcept Therapeutics President, Oncology Roberto Wandenkolk Vieira disclosed 4,068 common shares in an initial SEC Form 3 filing.
Filing also reports stock options covering 480,000 shares, including 200,000 at $21.63.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corcept Therapeutics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-382432), on September 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Corcept names Roberto Vieira as President, Oncology in initial beneficial ownership filing

You may also like

Crypto prices